GERANYL GERANYL TRANSFERASE INHIBITOR FOR DIABETIC LIVER INJURY

The present invention relates to pharmaceuticals. Specifically, the presentinvention relates to geranyl geranyl transferase inhibitor as therapeutic target fordiabetic liver injury. The present invention further relates to a particular dosageform of geranyl geranyl transferase inhibitor as hepatoprotective against diabeticliver injury.

Inventors

GURJEET THAKUR, ONKAR BEDI, EKTA

Patent File Number - 202011036305        Patent File Date - 24/08/2020